USNA
USNA
NYSE · Consumer products

Usana Health Sciences Inc

$13.49
+0.25 (+1.89%)
Financial Highlights (FY 2026)
Revenue
911.18M
Net Income
10.60M
Gross Margin
78.3%
Profit Margin
1.2%
Rev Growth
-2.5%
D/E Ratio
0.03
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 78.3% 78.3% 33.9% 33.9%
Operating Margin 4.0% 3.6% 16.8% 18.0%
Profit Margin 1.2% 1.1% 16.2% 16.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 911.18M 934.63M 119.49M 111.86M
Gross Profit 713.36M 731.73M 40.49M 37.91M
Operating Income 36.90M 34.07M 20.03M 20.12M
Net Income 10.60M 9.78M 19.36M 18.26M
Gross Margin 78.3% 78.3% 33.9% 33.9%
Operating Margin 4.0% 3.6% 16.8% 18.0%
Profit Margin 1.2% 1.1% 16.2% 16.3%
Rev Growth -2.5% -2.5% +14.6% -0.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 3.19M 3.19M 100.99M 110.95M
Total Equity 121.46M 121.46M 246.01M 260.40M
D/E Ratio 0.03 0.03 0.41 0.43
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 68.93M 67.17M 31.27M 29.25M
Free Cash Flow — — 14.98M 15.87M